Correction: Sato et al. Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance. Cancers 2024, 16, 869

Correction: Sato et al. Safety of Boron Neutron Capture Therapy with Borofalan(¹⁰B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance. Cancers 2024, 16, 869

Cancers (Basel). 2024 Sep 27;16(19):3297. doi: 10.3390/cancers16193297.

Mariko Sato^{1

2}, Katsumi Hirose^{1

2}, Satoshi Takeno^{3

4}, Teruhito Aihara^{3

5}, Keiji Nihei^{3

4}, Yoshihiro Takai², Toshimitsu Hayashi⁶, Kosuke Bando⁶, Hitomi Kimura⁶, Keisuke Tsurumi⁷, Koji Ono⁸

¹ Department of Radiation Oncology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan.
² Department of Radiation Oncology, Southern Tohoku BNCT Research Center, 7-10 Yatsuyamada, Koriyama 963-8052, Japan.
³ Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan.
⁴ Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan.
⁵ Department of Otolaryngology Head and Neck Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan.
⁶ Stella Pharma Corporation, ORIX Kouraibashi Building, 3-2-7 Kouraibashi, Chuo-ku, Osaka 541-0043, Japan.
⁷ Sumitomo Heavy Industries, Ltd., 5-2 Soubirakichou, Niihama 792-0001, Japan.
⁸ BNCT Joint Clinical Institute, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan.

The authors wish to make the following corrections to this paper [...].